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Abstract
Background: Hydroxysafflor Yellow A (HSYA), which is one of the most important active ingredients of the
Chinese herb Carthamus tinctorius L, is widely used in the treatment of cerebrovascular and cardiovascular diseases.
However, the potential protective effect of HSYA in spinal cord ischemia/reperfusion (I/R) injury is still unknown.
Methods: Thirty-nine rabbits were randomly divided into three groups: sham group, I/R group and HSYA group.
All animals were sacrificed after neurological evaluation with modified Tarlov criteria at the 48th hour after
reperfusion, and the spinal cord segments (L4-6) were harvested for histopathological examination, biochemical
analysis and terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) staining.
Results: Neurological outcomes in HSYA group were slightly improved compared with those in I/R group.
Histopathological analysis revealed that HSYA treatment attenuated I/R induced necrosis in spinal cords. Similarly,
alleviated oxidative stress was indicated by decreased malondialdehyde (MDA) level and increased superoxide
dismutase (SOD) activity after HSYA treatment. Moreover, as seen from TUNEL results, HSYA also protected neurons
from I/R-induced apoptosis in rabbits.
Conclusions: These findings suggest that HSYA may protect spinal cords from I/R injury by alleviating oxidative
stress and reducing neuronal apoptosis in rabbits.
Background
Paraplegia that results from spinal cord ischemia
remains a catastrophic complication of thoraco-abdom-
inal aortic surgery. Immediate or delayed paraplegia due
to I/R injury of the spinal cord has an incidence of
between 4% to 33% [1]. Great efforts, including surgical
techniques (such as temporary shunts or partial bypass),
pharmacological interventions (such as methylpredniso-
lone), and mechanical methods (such as hypothermia,
drainage of cerebrospinal fluid), have been focused on
the alleviation of spinal cord ischemia injury [2-4].
Despite all these efforts, no single technique has been
proved consistently effective in eliminating I/R-induced
neurological dysfunctions. Thus, further investigations
are required to find new drugs or techniques to protect
against spinal cord I/R injury [5].
Although the exact mechanism of spinal cord I/R
injury is not fully understood, oxygen-derived free radi-
cals are widely recognized as an important contributor
to neuronal damages [6]. Therefore, antioxidants repre-
sent a good candidate for the prevention of neurological
deficits related to spinal cord I/R injury.
In traditional oriental medicine, the flower of the saf-
flower plant, namely Carthamus tinctorius L,i se x t e n -
sively used for the treatment of cerebrovascular and
cardiovascular diseases. HSYA, which is the main che-
mical component of the safflower yellow pigments, has
been demonstrated to have potent antioxidative effect in
vitro [7]. Recent studies revealed that HSYA could alle-
viate I/R injury of the lung, heart [8] and brain [9] via
scavenging of free radicals. However, it remains uncer-
tain yet whether HSYA could protect against spinal cord
I/R injury.
The purpose of this study was to investigate the pro-
tective efficacy of HSYA on the neurological, biochem-
ical and histopathological outcomes of spinal cord I/R
injury in rabbits. We hypothesized that HSYA might
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any medium, provided the original work is properly cited.protect spinal cords from I/R injury via reduction of oxi-
dative stress and inhibition of apoptosis.
Methods
HSYA preparation
HSYA powder with 98.0% purity was purchased from
Shandong Lvye Natural Medicine Research and Devel-
opment Center (Shandong, China). HSYA solution was
prepared and injected in the form of Ringer’s ethyl pyru-
vate solution at a concentration of 1 mg/ml.
General animal care and setting of groups
This study was performed in Bone Tumor Institute of
Tangdu Hospital, Fourth Military Medical University.
All experimental protocols were carried out in accor-
dance with the National Institutes of Health Guide for
the Care and Use of Laboratory Animals (NIH publica-
tions No. 80-23). In total, 39 adult male New Zealand
rabbits, 4 to 5-month old and 2.2 to 2.5-kg body
weight, were used and randomly divided into three
groups. Animals in sham group (n = 13) were sub-
jected to only laparotomy without aortic occlusion or
any pharmacological treatment. The 13 rabbits in
HSYA group were given 10.0m g / k gH S Y At h r o u g h
left ear vein 30 min before occlusion and again at the
onset of reperfusion. The other 13 rabbits in I/R group
underwent similar procedures as animals in HSYA
group but received an equivalent dose of saline instead
of HSYA.
Surgery preparation
After an overnight fast with unrestricted access to water,
the rabbits were anesthetized with pentobarbital sodium
(30 mg/kg, IV) and allowed to breathe spontaneously.
Additional doses of pentobarbital sodium were given
during the surgery when needed. The left ear vein was
cannulated with a 22-gauge catheter to measure the
proximal blood pressure and administrate HSYA.
Another catheter was inserted into the left femoral
artery to measure the distal blood pressure. Blood pres-
sure was monitored continuously by using a calibrated
pressure transducer connected to an invasive pressure
monitor (Spacelabs Medical Inc., Redmond, WA). Dur-
ing the surgery, rectal temperature was maintained at
about 38.5°C by an overhead lamp. Arterial blood was
sampled at preischemia, 10 min after ischemia, and 10
min after reperfusion, respectively, for the determination
of arterial oxygen tension (PaO2), arterial carbon diox-
ide tension (PaCO2), pH, and plasma glucose. Arterial
blood gases were measured by means of the OMNI
Modular System (AVL List GmbH Medizintechnik,
Kleiststrabe, Graz, Austria).
Ischemia-reperfusion procedure
Spinal cord I/R injury models were established accord-
ing to Savas’ description [10]. Animals were placed in
supine position. After sterile preparation, a 10 cm mid-
line incision was made to expose the abdominal aorta.
Following anticoagulation with 400 unit’s heparin, the
abdominal aorta was cross-clamped for 20 min using
atraumatic vascular clamps at the level of the left renal
artery. At the end of the occlusion period, the clamp
was removed, and the abdominal wall was subsequently
carefully closed in separate layers using 4-0 nylon
suture. The animals were placed under an overhead
lamp to maintain body temperature until recovery from
anesthesia. They were then returned to their home cage,
and given prophylactic antibiotic (gentamicin; 40,000
IU) and saline (5 ml, twice a day for 5 days, to prevent
dehydration). Bladders were voided manually twice a
day until normal function returned.
Neurological evaluation
Neurological status of the animals was assessed at 24 h
and 48 h after reperfusion by an independent observer
who had no prior knowledge of the experimental proto-
col and grouping. Modified Tarlov criteria was used to
grade the motor function of hind limbs [11]: grade 0, no
movement of the lower limbs; grade 1, minimal move-
ment; grade 2, good movement but unable to stand;
grade 3, able to stand and walk but unable to hop nor-
mally; and grade 4, normal recovery.
Histological study
Forty-eight hours after I/R injury, 8 rabbits from each
g r o u pw e r er e a n e s t h e t i z e dw i t hp e n t o b a r b i t a ls o d i u m
(40 mg/kg). Then intracardiac perfusion was performed
with 1000 ml heparinized saline and 500 ml 10% buf-
fered formalin. After perfusion, the lumbar spinal cord
(L4-6 segments) was removed immediately, immersed
in 10% formaldehyde and stored at 4°C for 48 h. After
dehydration in graded ethanol, the spinal cord speci-
mens were embedded in paraffin. Coronal sections of
t h es p i n a lc o r ds e g m e n tw e r ec u ta tat h i c k n e s so f
5 μm and stained with hematoxylin and eosin (H&E)
for evaluation of structural changes. Injured neurons
were identified by intensely eosinophilic cytoplasm,
loss of Nissl substance and pyknotic nuclei. The
remaining normal neurons in the ischemic ventral
spinal cord in each animal, judged by their morpholo-
gical appearance, were counted in three sections
selected randomly from the rostral, middle, and caudal
levels of the L5 segment and then averaged. The num-
bers of normal neurons per section were compared
among the three groups.
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Five rabbits from each group were reanesthetized with
pentobarbital sodium (40 mg/kg) 48 h after I/R injury.
The lumbar spinal cord was immediately removed,
washed twice with cold saline solution, placed into glass
bottles, labeled and stored at -70°C until processing
(maximum 10 h). Spinal cord tissue samples were cut
into small pieces, weighed, and homogenized in ice-cold
Tris-HCl buffer (50 mmol, pH 7.4). The homogenate
was then centrifuged at 5000 g for 30 min to remove
debris. For further extraction, the supernatant solution
was extracted with an equal volume of an ethanol/
chloroform mixture (5/3, volume per volume [v/v]).
After the second centrifugation at 5000 g for 60 min,
the clear upper layer (the ethanol phase) was taken and
used for SOD activity assay. MDA level was determined
in the homogenate. Protein concentrations were mea-
sured according to Lowry’s procedure [12].
Tissue MDA levels were determined by the method
described by Wasowicz et al. [13]. Briefly, MDA was
reacted with thiobarbituric acid by incubating for 1 h at
95-100°C. After the reaction, fluorescence intensity was
measured in the n-butanol phase with a fluorescence
spectrophotometry (Hitachi, Model F-4010) (excitation
at 525 nm, emission at 547 nm), by comparing with a
standard solution of 1,1,3,3 tetraethoxypropane. Results
were expressed in terms of nmol/g wet tissue.
The level of total (Cu-Zn and Mn) SOD was studied
using the Yi-Sun method, which is based on the inhibi-
tion of nitroblue tetrazolium reduction by the xanthine
oxidase system as a superoxide generator [14]. Activity
was assessed in the ethanol phase of the spinal cord
homogenate after ethanol/chloroform mixture was added
to the same volume of sample and centrifuged. One unit
of SOD was defined as the enzyme amount showing 50%
inhibition. SOD activity was expressed as U/mg protein.
TUNEL staining
TUNEL staining was performed on paraffin sections,
using an in situ cell death detection kit (Roche,
Germany), in accordance with the manufacture’s instruc-
tions. Hematoxylin was used to counterstain the sections.
A negative control was similarly performed except for
replacing TUNEL reaction mixture with label solution
(without terminal transferase). Quantitative analysis was
performed blindly by counting the number of TUNEL
positive neurons in the ventral horns in five microscopic
fields. The average number of TUNEL positive neurons
in each group was calculated from the five specimens.
Statistical analysis
All values are presented as mean ± SEM. Statistical ana-
lysis was performed with the help of SPSS 12.0. Kruskal-
Wallis nonparametric analysis was followed by Mann-
Whitney U-test to analyze neurological scores and the
numbers of viable motor neurons and apoptotic motor
neurons in the anterior spinal cord. MDA content and
SOD activity were analyzed with one-way analysis of
variance (ANOVA), followed by SNK-q test for multiple
comparisons. A P value less than 0.05 was considered to
be statistically different.
Results
Physical parameters
There was no difference between groups at any time
point in terms of hemodynamics, rectal temperature,
arterial pH, PaCO2, PaO2, and blood glucose concentra-
tions. The distal blood pressure was about 70 to 80
mmHg before blocking the abdominal aorta and it
decreased to 10 to 15 mmHg during the period of ische-
mia. Ten minutes after the beginning of reperfusion, the
value of the distal blood pressure was recovered to
approximately 90% preischemic level (data not shown).
Neurological function evaluation
The outcomes of neurological evaluation are presented
in Table 1. Animals in sham group displayed no neuro-
logical abnormalities at the 24th and 48th hour after
reperfusion. The neurological scores in I/R group and
HSYA group were significantly lower than that of sham
group at both the 24th hour and 48th hour. Animals in
HSYA group exhibited better neurological outcomes
than I/R group at the 24th and 48th hour after
reperfusion.
Table 1 The neurological scores of rabbits at 24 h and 48 h after reperfusion (n = 13)
Tarlov Score Sham Group I/R Group HSYA-treatment Group
24 h 48 h 24 h 48 h 24 h 48 h
00 0 0 2 0 0
10 0 3 1 0 1 4
20 0 8 1 4 6
30 0 2 0 7 3
41 3 1 3 0 0 1 0
Average Score 4 4 1.92 ± 0.64* 0.92 ± 0.49* 2.62 ± 0.77 *
,# 1.92 ± 0.76*
,#
* P < 0.05, compared with Sham group.
# P < 0.05, compared with I/R group.
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Representative histopathological photographs of sec-
tions are shown in Figure 1. Representative image
from an animal with Tarlov score 4 in sham group
showed no signs of histopathological abnormalities
(Figure 1A). In contrast, the image from an animal
with Tarlov score 0 in I/R group exhibited necrotic
changes with pronounced vacuolization, intensely eosi-
nophilic cytoplasm, Nissl granule loss, and pyknosis
(Figure 1B). HSYA treatment attenuated I/R-induced
histopathological abnormalities. Representative images
from HSYA group exhibited mild destruction with sig-
nificantly more normal neurons (Figure 1C and Figure
1D).
Biochemical analysis
As seen from Table 2, spinal cord MDA level of I/R
group was significantly higher than that of sham group
(p < 0.05). This increase in MDA content was counter-
acted by HSYA administration. As for SOD activity, a
significant decrease was observed in I/R group when
compared with that of sham group (p < 0.05). In ani-
mals treated with HSYA, SOD activity was markedly
higher than that of I/R group.
TUNEL staining
The results of TUNEL staining are shown in Figure 2.
While no TUNEL-positive neurons could be identified
in sham group (Figure. 2A), numerous neurons with
Figure 1 Micrographs of hematoxylin and eosin staining (×400). (A) The micrographs from an animal with Tarlov score 4 in sham group
showed no histopathology abnormity. (B) The image from an animal with Tarlov score 0 in I/R group. The arrows indicate ischemia neuron cells
showing intensely eosinophilic cytoplasm, Nissl body loss, and pyknosis. The arrow heads indicate pronounced vacuolization in the anterior horn.
(C) The micrographs from an animal with Tarlov score 2 in HSYA-treatment group revealed alleviated destruction after HSYA treatment. (D) The
number of normal motor neurons in the anterior horn 48 h after reperfusion. * P < 0.05 versus sham group;
# P < 0.05 versus I/R group.
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(Figure. 2B). HSYA administration reduced the number
of apoptotic neurons (Figure. 2C). As seen from the
quantitative analysis of neuronal apoptosis (Figure. 2D),
the number of TUNEL-positive neurons decreased
significantly after the treatment of HSYA, suggesting
that HSYA may protect spinal cords from I/R-induced
apoptosis.
Discussion
This study demonstrates a considerable neuroprotective
effect of HSYA against spinal cord ischemia/reperfusion
injury in rabbits. Animals treated with HSYA exhibited
improved neurological scores, reduced tissue destruction
and oxidative stress, and decreased neuronal apoptosis.
Reactive oxygen species (ROS) induced damage has
been accepted as an important contributor in post-
ischemic cell injury and cell death in spinal cords [15].
ROS, consisting of oxygen free radicals and associated
Table 2 Effect of HSYA on MDA level and SOD activity
(n = 5)
Experimental conditions MDA (nm/gww) SOD (U/mg protein)
Sham Group 51.87 ± 10.82 0.65 ± 0.04
I/R Group 135.32 ± 17.48* 0.44 ± 0.09*
HSYA Group 101.36 ± 19.06*
,# 0.54 ± 0.08*
,#
* p < 0.05, compared with sham group,
# p < 0.05, compared with I/R group.
Figure 2 Micrographs of TUNEL staining and quantification of apoptotic motor neurons 48 h after reperfusion (×400). (A) No TUNEL-
positive neurons could be detected in sham group. (B) Many TUNEL-positive neuron with intense nucleus staining were visible in I/R group. (C)
Only a small number of positively stained neurons were observed in the HSYA-treatment group. The arrows indicate normal motor neurons, and
the arrowheads indicate TUNEL-positive motor neurons. (D) Quantitative analysis of the number of TUNEL-positive cells in the anterior horn of
spinal cord of lumbar segments in three groups. * P < 0.05 versus I/R group. N.D. = not detected. The arrows indicate normal motor neurons,
and the pointers indicate TUNEL-positive motor neurons.
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[16,17]. In pathological conditions, including I/R inju-
ries, ROS are overproduced while antioxidative enzymes
are inactivated and antioxidants over-consumed [6].
When the production of ROS overwhelms endogenous
antioxidant defenses, excessive ROS would result in the
self-perpetuating free radical reaction of lipid peroxida-
tion, which could, subsequently, induce membrane
damage, cell lysis, organelle dysfunction, and calcium
dyshomeostasis. Since spinal cords are characterized by
large lipid content and high oxygenation, they are espe-
cially susceptible to lipid peroxidation related cellular
damage [18]. Therefore, salvaging the spinal cord from
oxidative damage by using antioxidant therapies is an
important area of continuing investigation in spinal cord
I/R injuries. As a matter of fact, high-dose of methyl-
prednisolone, which is considered the only widely
accepted pharmacological therapy currently in use in
human spinal cord injuries, confers neuroprotection
through its ability to inhibit post-traumatic lipid peroxi-
dation and inflammatory responses.
In traditional Chinese medicine, the flower of the saf-
flower plant, Carthamus tinctorius L., has been exten-
sively used in the treatment of cerebrovascular and
cardiovascular diseases. The extracts of Carthamus tinc-
torius L. contain yellow and red pigments including
hydroxysafflor yellow A (HSYA), safflor yellow B, safflo-
min A, safflomin C, as well as other chemicals. Among
all these components, HSYA has been demonstrated as
the most active chemicals. In 2003, Zhu et al. [19] first
reported the neuroprotective effects of HSYA on cere-
bral ischemic injury in both in vivo and in vitro studies.
Considering that oxidative stress is an important cause
of tissue damage after I/R injury, Jin et al. [7] examined
the possible antioxidative effect of HSYA and demon-
strated that HSYA could scavenge hydroxyl radicals and
inhibit lipid peroxidation in vitro. The antioxidative
effect of HSYA, as proposed by Jin et al., may be attrib-
uted to its multiple phenolic hydroxyl groups. In accor-
dance with Jin’s study, Tian et al. [20,21] further
demonstrated that HSYA protected the cortex mito-
chondrial against I/R injuries through scavenging of free
radicals, reduction of lipid peroxidation, inhibition of
Ca
2+ overload, and inhibition of the opening of mito-
chondrial permeability transition pores (mtPTP). Later,
Wei’s study of focal cerebral ischemia reperfusion injury
showed that, compared with animals that received no
pharmacological treatment, animals treated with HSYA
revealed reduced MDA content, increased SOD activity
and total antioxidative capability in the brain and serum
[9]. This study provided direct in vivo evidence that
HSYA confers neuroprotection through its antioxidative
action. Moreover, as reported by Zhu [22] and Ye [23],
the neuroprotective effect of HSYA might also be
attributed to its inhibition of thrombosis formation and
platelet aggregation, its regulation on PGI2/TXA2 (pros-
taglandin I2/thromboxane A2) ratio and blood rheologi-
cal changes, as well as its suppression of inflammatory
responses.
Although beneficial effects of HSYA have been
demonstrated in I/R injuries of various organs, its effect
on spinal cord I/R injuries has not been studied yet.
Thus, we conducted the present study to investigate the
possible neuroprotective effect of HSYA against spinal
cord I/R injuries in rabbits. The dose of 10 mg/kg was
chosen based on our prior preliminary study and related
references which demonstrated remarkable protection of
HSYA against brain I/R injury at the dose of 8 mg/kg in
rats [9].
The hypothesis that HSYA could protect against
spinal cord I/R injury was accepted because neurological
evaluation after reperfusion revealed improved motor
function of hinder limbs in animals that received HSYA
treatment. However, neurological scores of animals in
HSYA group were still lower than that of sham group,
suggesting that HSYA alone may not be effective
enough to completely restore motor functions. The ben-
eficial effect of HSYA was also confirmed by histopatho-
logical study. While severe vacuolization of gray matter
and degeneration of motor neurons were observed in
the non-treated group, only mild tissue destruction with
significant more normal motor neurons were detected
in the HSYA-treated group.
To further answer the question of whether the protec-
tive effect of HSYA was related to its antioxidative effi-
ciency, we performed the biochemical analysis to study
the changes in MDA level and SOD activity in spinal
cords. Lipid peroxidation induced by ROS is a primary
cause of reperfusion injury in spinal cords when blood
flow is restored, and the level of MDA, a relatively stable
end product of lipid peroxidation, is considered as indir-
ect evidence of reperfusion injury. In accordance with
other researches, a significant increase in MDA content
was observed in the spinal cord tissue of rabbits in I/R
group [24]. HSYA significantly attenuated the increase
of MDA in the tissue. We therefore concluded that the
protective effect of HSYA in I/R-induced spinal cord
injury may be partly related to its anti-lipid peroxidative
properties. SOD, a protective enzyme that scavenges the
superoxide radical by catalyzing its dismutation to
hydrogen peroxide and oxygen, is the first line of
defense against free radical generation. The overproduc-
tion of ROS can cause SOD consumption and depletion.
In the current study, SOD activity of the spinal cord tis-
sue was greatly decreased by I/R, and was restored by
HSYA treatment. However, the precise mechanism of
the effect of HSYA on SOD activity remains to be
determined.
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neuronal cell death after I/R injury [25], we further stu-
died the effect of HSYA on neuronal apoptosis by
TUNEL staining. Compared with control group, HSYA
significantly reduced the number of TUNEL-positive
cells in the anterior horn of spinal cords. This protective
effect of HSYA against neuronal apoptosis may be
related to its antioxidative efficiency because the major
mechanism of I/R induced apoptosis is attributed to
ROS release [26]. Recent studies have revealed that anti-
oxidants attenuated ischemic neuronal apoptosis
through Bcl-2 up-regulation and Bax down-regulation
[27]. The exact mechanism of HSYA’s anti-apoptotic
effect will be explored in further studies.
Conclusions
The results of this study indicate that the potent antiox-
idant HSYA could protect spinal cords from I/R injury
by alleviating oxidative stress and reducing neuronal
apoptosis. Neurological evaluation, histological examina-
tion, biochemical study, and TUNEL staining all
revealed improved outcomes in animals treated with
HSYA. Considering that I/R injury of spinal cords is a
complicated biological process, we suppose that more
efficacious therapies may be achieved by the combina-
tion of several pharmacological agents targeting at dif-
ferent pathological pathways. Therefore, in future
researches, besides further elucidation of the protective
effect of HSYA, we will also explore important mechan-
isms of spinal cord I/R injury and try to combine several
pharmacological agents to find a more effective pharma-
cological strategy to protect against spinal cord I/R
injury.
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